BCMA
B-cell Maturation Antigen. Target of multiple myeloma CAR-T (idecabtagene vicleucel, ciltacabtagene autoleucel), bispecifics (teclistamab, elranatamab), and ADC (belantamab mafodotin).
No Treatments found for this biomarker.
B-cell Maturation Antigen. Target of multiple myeloma CAR-T (idecabtagene vicleucel, ciltacabtagene autoleucel), bispecifics (teclistamab, elranatamab), and ADC (belantamab mafodotin).
No Treatments found for this biomarker.